S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

REVB Revelation Biosciences Inc

0.3005

-0.0019 (-0.63%)

Dec 24 2024 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Revelation Biosciences (NASDAQ:REVB)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Revelation Biosciences Charts.

Revelation Biosciences (NASDAQ:REVB)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Revelation Biosciences Charts.

Revelation Biosciences Inc News

Revelation Biosciences Inc. Announces Exercise of Warrants for $4 Million in Gross Proceeds
Tuesday 3 December 2024 (3 weeks ago) • Business Wire

Revelation Biosciences Inc. Announces FDA Acceptance of Gemini IND
Monday 2 December 2024 (3 weeks ago) • Business Wire

Revelation Biosciences, Inc. Completes the GMP Manufacture of Gemini Clinical Drug Supply
Tuesday 12 November 2024 (1 month ago) • Business Wire

Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2024
Friday 8 November 2024 (2 months ago) • Business Wire

Revelation Biosciences’ Gemini Induces Dose Dependent Significant Increases in IL-10
Tuesday 24 September 2024 (3 months ago) • Business Wire

Form S-3 - Registration statement under Securities Act of 1933
Tuesday 3 September 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 26 August 2024 (4 months ago) • Edgar (US Regulatory)

Revelation Biosciences Inc. Announces Exercise of Warrants for $3.8 Million in Gross Proceeds
Wednesday 21 August 2024 (4 months ago) • Business Wire

Form 8-K - Current report
Monday 19 August 2024 (4 months ago) • Edgar (US Regulatory)

Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2024
Friday 9 August 2024 (5 months ago) • Business Wire

Form 8-K - Current report
Friday 2 August 2024 (5 months ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Sunday 28 July 2024 (5 months ago) • Edgar (US Regulatory)

More Revelation Biosciences Inc News Articles

Enanta Pharmaceuticals

ELine Entertainment (CE)

Hallmark Venture (PK)

Asia Broadband (PK)

Virexit Technologies (PK)

KULR Technology

Intergrated Cannabis Sol... (PK)

Anavex Life Sciences

Impact Fusion (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions